StockData
Amneal Pharmaceuticals, Inc. logo

Amneal Pharmaceuticals, Inc. (AMRX) stock

AMRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3062% above fair value
$21.23−0.15 (-0.70%)

Close on Nov 16, 2026Market cap $6.78BP/E 43.3Yield –

Amneal Pharmaceuticals profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Amneal Pharmaceuticals's profit margin for the twelve months ending Jun 30, 2026 was 5.0%. For fiscal 2025 it was 2.4%, against -4.2% the year before. The highest annual figure on record is 3.4% in fiscal 2020.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 20252.4%+6.6
FY2024Dec 31, 2024-4.2%−0.7
FY2023Dec 31, 2023-3.5%+8.7
FY2022Dec 31, 2022-12.2%−12.9
FY2021Dec 31, 20210.6%−2.8
FY2020Dec 31, 20203.4%+40.5
FY2019Dec 31, 2019-37.1%−35.9
FY2018Dec 31, 2018-1.2%−1.2
FY2017Dec 31, 20170.0%+0.0
FY2016Dec 31, 20160.0%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 20267.2%+4.1
Q1 FY2026Mar 31, 20268.6%+6.9
Q4 FY2025Dec 31, 20254.3%+8.6
Q3 FY2025Sep 30, 20250.3%+0.3
Q2 FY2025Jun 30, 20253.1%+2.2
Q1 FY2025Mar 31, 20251.8%+15.7
Q4 FY2024Dec 31, 2024-4.3%+11.7
Q3 FY2024Sep 30, 2024-0.0%−1.6
Q2 FY2024Jun 30, 20240.9%−1.1
Q1 FY2024Mar 31, 2024-13.9%−12.7
Q4 FY2023Dec 31, 2023-16.0%−14.0
Q3 FY2023Sep 30, 20231.6%+3.0
Q2 FY2023Jun 30, 20232.0%+45.3
Q1 FY2023Mar 31, 2023-1.2%+0.5
Q4 FY2022Dec 31, 2022-2.0%+2.1
Q3 FY2022Sep 30, 2022-1.4%+0.1
Q2 FY2022Jun 30, 2022-43.3%−48.9
Q1 FY2022Mar 31, 2022-1.8%−4.4
Q4 FY2021Dec 31, 2021-4.1%−2.7
Q3 FY2021Sep 30, 2021-1.5%+2.7
Q2 FY2021Jun 30, 20215.6%+10.8
Q1 FY2021Mar 31, 20212.6%−21.6
Q4 FY2020Dec 31, 2020-1.3%+67.6
Q3 FY2020Sep 30, 2020-4.2%+65.9
Q2 FY2020Jun 30, 2020-5.2%−1.0
Q1 FY2020Mar 31, 202024.2%+34.9
Q4 FY2019Dec 31, 2019-68.9%−67.1
Q3 FY2019Sep 30, 2019-70.1%−71.5
Q2 FY2019Jun 30, 2019-4.2%+0.1
Q1 FY2019Mar 31, 2019-10.7%−10.7
Q4 FY2018Dec 31, 2018-1.8%−1.8
Q3 FY2018Sep 30, 20181.4%+1.4
Q2 FY2018Jun 30, 2018-4.3%−4.3
Q1 FY2018Mar 31, 20180.0%–
Q4 FY2017Dec 31, 20170.0%–
Q3 FY2017Sep 30, 20170.0%–
Q2 FY2017Jun 30, 20170.0%–

More Amneal Pharmaceuticals figures

See a number that looks wrong?